Providence Capital Advisors, LLC Sanofi Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 54,800 shares of SNY stock, worth $2.61 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

54,800

Previous 54,399 0.74%

Holding current value

$2.61 Million

Previous $2.64 Million 19.7%

% of portfolio

0.65%

Previous 0.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$48.54 - $58.53 $19,464 - $23,470	401 Added 0.74%	54,800 $3.16 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $37,537 - $41,647	827 Added 1.54%	54,399 $2.64 Million
Q1 2024 May 13, 2024	SELL	$45.75 - $52.48 $42,273 - $48,491	-924 Reduced 1.7%	53,572 $2.6 Million
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $28,124 - $30,470	552 Added 1.02%	54,496 $2.92 Million
Q2 2023 Aug 10, 2023	BUY	$50.45 - $57.18 $64,929 - $73,590	1,287 Added 2.44%	53,944 $2.91 Million
Q1 2023 May 17, 2023	BUY	$45.86 - $54.45 $131 Million - $156 Million	2,859,972 Added 50871.08%	2,865,594 $156 Million
Q1 2023 May 17, 2023	SELL	$45.86 - $54.45 $129 Million - $153 Million	-2,812,937 Reduced 98.16%	52,657 $2.87 Million
Q1 2023 May 10, 2023	SELL	$45.86 - $54.45 $3 Million - $3.57 Million	-65,500 Reduced 92.1%	5,622 $305,000
Q4 2022 Feb 07, 2023	SELL	$38.86 - $48.55 $21,334 - $26,653	-549 Reduced 0.77%	71,122 $3.44 Million
Q3 2022 Nov 09, 2022	BUY	$37.22 - $100.5 $851,965 - $2.3 Million	22,890 Added 46.92%	71,671 $2.73 Million
Q2 2022 Aug 09, 2022	BUY	$48.99 - $57.46 $92,297 - $108,254	1,884 Added 4.02%	48,781 $2.44 Million
Q1 2022 May 12, 2022	BUY	$48.48 - $53.65 $174,673 - $193,300	3,603 Added 8.32%	46,897 $2.41 Million
Q4 2021 Feb 11, 2022	BUY	$47.07 - $52.35 $84,678 - $94,177	1,799 Added 4.34%	43,294 $2.17 Million
Q3 2021 Nov 09, 2021	BUY	$47.89 - $53.12 $183,418 - $203,449	3,830 Added 10.17%	41,495 $2 Million
Q2 2021 Aug 09, 2021	BUY	$49.36 - $54.25 $112,047 - $123,147	2,270 Added 6.41%	37,665 $1.98 Million
Q1 2021 May 13, 2021	BUY	$45.46 - $50.51 $115,422 - $128,244	2,539 Added 7.73%	35,395 $1.75 Million
Q4 2020 Feb 11, 2021	BUY	$45.3 - $51.62 $241,947 - $275,702	5,341 Added 19.41%	32,856 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$49.47 - $53.77 $44,127 - $47,962	892 Added 3.35%	27,515 $1.38 Million
Q2 2020 Aug 04, 2020	SELL	$42.91 - $52.5 $405,027 - $495,547	-9,439 Reduced 26.17%	26,623 $1.36 Million
Q1 2020 May 12, 2020	BUY	$38.02 - $51.66 $53,189 - $72,272	1,399 Added 4.04%	36,062 $1.58 Million
Q4 2019 Feb 13, 2020	BUY	$44.25 - $50.86 $25,842 - $29,702	584 Added 1.71%	34,663 $1.74 Million
Q3 2019 Nov 13, 2019	BUY	$40.34 - $46.64 $15,934 - $18,422	395 Added 1.17%	34,079 $1.58 Million
Q2 2019 Aug 13, 2019	BUY	$40.43 - $44.3 $50,860 - $55,729	1,258 Added 3.88%	33,684 $1.46 Million
Q1 2019 May 08, 2019	BUY	$40.83 - $45.43 $32,092 - $35,707	786 Added 2.48%	32,426 $1.44 Million
Q4 2018 Feb 01, 2019	BUY	$41.48 - $45.59 $54,836 - $60,269	1,322 Added 4.36%	31,640 $1.37 Million
Q3 2018 Nov 08, 2018	BUY	$40.0 - $44.84 $12,080 - $13,541	302 Added 1.01%	30,318 $1.35 Million
Q2 2018 Aug 08, 2018	BUY	$37.63 - $41.22 $355,979 - $389,941	9,460 Added 46.02%	30,016 $1.2 Million
Q1 2018 May 10, 2018	BUY	$38.98 - $45.76 $81,429 - $95,592	2,089 Added 11.31%	20,556 $824,000
Q4 2017 Feb 12, 2018	BUY	$42.86 - $50.61 $791,495 - $934,614	18,467	18,467 $794,000

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Sanofi Transaction History